SecBot SecBot
SECBOTREPLAY Home › Report › SNGX

SNGX · Soligenix filed a prospectus supplement to increase its at-the-market…

SOLIGENIX, INC. · 8-K filed Jun 26, 2026 at 16:06 ET

At the news

BEARISHIMPACT 6/10

8-K filed Jun 26, 2026 at 16:06 ET

Soligenix filed a prospectus supplement to increase its at-the-market (ATM) equity offering capacity by $2.5 million, bringing total authorized under the Rodman & Renshaw sales agreement to $8.906 million. The company has already sold approximately $6.234 million of shares under prior supplements, meaning up to $2.672 million in additional common stock could be issued. For a $9 million market cap company, this represents potential dilution of ~28% and signals ongoing cash needs.

  • ATM offering capacity increased by $2.5 million to a total of $8.906 million under the Sales Agreement with Rodman & Renshaw LLC.
  • Prior sales of approximately $6.234 million of common stock had been completed under earlier prospectus supplements covering up to $6.406 million.
  • Up to $2.672 million in additional shares may be sold at market prices, representing roughly 28% of the current $9 million market cap.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access